tm logo
BRIGHT PEAK
Live/Registered
REGISTERED

on 11 Jan 2022

Last Applicant/ Owned by

Serial Number

79285070 filed on 25th Mar 2020

Registration Number

6610085 registered on 11th Jan 2022

in the Principal Register

Correspondent Address

MONICA RIVA TALLEY

Monica Riva Talley

1100 New York Avenue, N.W.

Washington, DC, 20005

Filing Basis

No Filing Basis

Disclaimer

NO DATA

BRIGHT PEAK

Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune diseases, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine diseases, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, eye and adnexa, ear and mastoid process disorders, diseases of the circulatory system, respi Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune diseases, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine diseases, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, eye and adnexa, ear and mastoid process disorders, diseases of the circulatory system, respiratory system, and digestive system, skin and subcutaneous tissue disorders, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, disorders and abnormalities relating to pregnancy and childbirth, certain conditions originating in the puerperium and perinatal periods, congenital malformations and deformations, and chromosomal abnormalities; medical and veterinary preparations, namely, recombinant or chemically synthesized and optimized proteins; preparations for destroying vermin; fungicides, herbicides; biotechnological preparations, namely, recombinant or chemically synthesized and optimized proteins for medical use; enzymes for medical use; enzymes for veterinary use; biological and chemical reagents for medical or veterinary use; amino acids for medical use; amino acids for veterinary use; peptides for medical or veterinary use, namely, for the treatment of cancer, autoimmune diseases, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine diseases, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, eye and adnexa, ear and mastoid process disorders, diseases of the circulatory system, respiratory system, and digestive system, skin and subcutaneous tissue disorders, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, disorders and abnormalities relating to pregnancy and childbirth, certain conditions originating in the puerperium and perinatal periods, congenital malformations and deformations, and chromosomal abnormalities; proteins for medical or veterinary use, namely, recombinant or chemically synthesized and optimized proteins for detection and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, autoimmune diseases, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, nutritional diseases, mental and behavioral disorders, diseases of the nervous system, eye and adnexa, ear and mastoid process disorders, diseases of the circulatory system and digestive system, skin and subcutaneous tissue disorders, diseases of the musculoskeletal system and connective tissue, disorders and abnormalities relating to pregnancy and childbirth, certain conditions originating in the puerperium and perinatal periods, congenital malformations and deformations, and chromosomal abnormalities; pharmaceutical preparations for cancer treatment; biopharmaceutical preparations for cancer treatment; pharmaceutical compositions and preparations for cancer prevention and treatment; pharmaceutical preparations for treatment of autoimmune and inflammatory diseases; pharmaceutical preparations for treatment of skin diseases; pharmaceutical preparations for treatment of neurodegenerative, metabolic and ophthalmological diseases

Class [042]
Computer & Software Services & Scientific Services


Scientific and technological services, namely, scientific research, scientific analysis, and scientific testing in the field of biotechnology and new product research and design services relating thereto; research and development in the field of biotechnology; consulting services in the field of biotechnology; scientific research services in the field of proteins, peptides and antibodies, and scientific advice relating thereto; scientific research services for medical purposes in the field of cancer and autoimmune diseases and scientific advice relating thereto

Mark Details


Serial Number

No 79285070

Mark Type

No Service Mark

Attorney Docket Number

No 4697.0010000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
11th Jan 2022REGISTERED-PRINCIPAL REGISTER
04th Nov 2021NOTIFICATION PROCESSED BY IB
03rd Nov 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
26th Oct 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26th Oct 2021PUBLISHED FOR OPPOSITION
13th Oct 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13th Oct 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06th Oct 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06th Oct 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06th Oct 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED